Last Price
18.96
Today's Change
-0.89 (4.48%)
Day's Change
18.96 - 19.98
Trading Volume
614,187
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Ramy Farid Ph.D. Dr. Ramy Farid Ph.D.
Full Time Employees: 867 867
IPO Date: 2020-02-06 2020-02-06
CIK: 0001490978 0001490978
ISIN: US80810D1037 US80810D1037
CUSIP: 80810D103 80810D103
Beta: 1.50 1.50
Last Dividend: 0.00 0.00
Dcf Diff: 46.67 46.67
Dcf: -23.32 -23.32
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.